ST. LOUIS, April 6, 2012 /PRNewswire/ -- On April 6, 2012, Medco Health Solutions, Inc., a wholly owned subsidiary of Express Scripts Holding Company (NASDAQ: ESRX), issued a notice of redemption to the holders of its 7.25% Senior Notes due August 15, 2013 (Cusip No. 58405UAC6) (the " Notes"), which were issued under the Indenture, dated as of August 12, 2003, between Medco and U.S. Bank Trust National Association, as trustee. As indicated in the notice of redemption, Medco intends to redeem the Notes, pursuant to the optional redemption provisions of the Indenture, on May 7, 2012. The redemption of the Notes, which is expected to be financed by Express Scripts, primarily from cash on hand, is consistent with Express Scripts' previously announced plans to de-lever following the completion of the Medco acquisition.
On April 6, 2012, Medco notified the NYSE of its intention to withdraw the Notes from listing on the NYSE. Such withdrawal is being effected in connection with the redemption of the Notes discussed above. In accordance with applicable U.S. securities laws, Medco intends to file a Form 25 with the U.S. Securities and Exchange Commission to notify the Commission of its withdrawal of the Notes from listing on the NYSE and its intention to withdraw the Notes from registration under Section 12(b) of the U.S. Securities Exchange Act of 1934, as amended. Medco has not arranged for listing and/or registration of the Notes on another national securities exchange or for quotation of the Notes in a quotation medium.
About Express Scripts Express Scripts is leading the way toward creating better health and value for patients through Consumerology®, the advanced application of the behavioral sciences to healthcare. This approach is helping millions of members realize greater healthcare outcomes and lowering cost by assisting in influencing their behavior.
Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services including network-pharmacy claims processing, home delivery services, specialty benefit management, benefit-design consultation, drug-utilization review, formulary management, and medical and drug data analysis services. The company also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.More information can be found at www.express-scripts.com. EXPRESS SCRIPTS FORWARD LOOKING STATEMENTS Cautionary Note Regarding Forward-Looking Statements
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV